Quadrant Capital Group LLC West Pharmaceutical Services Inc Transaction History

Quadrant Capital Group LLC

$1.42 Billion
Q3 2024

A detailed history of Quadrant Capital Group LLC transactions in West Pharmaceutical Services Inc stock. As of the latest transaction made, Quadrant Capital Group LLC holds 594 shares of WST stock, worth $200,843. This represents 0.01% of its overall portfolio holdings.

Number of Shares

594

Previous 657 9.59%

Holding current value

$200,843

Previous $216,000 17.59%

% of portfolio

0.01%

Previous 0.02%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$277.16 - $333.3 $17,461 - $20,997	-63 Reduced 9.59%	594 $178,000
Q2 2024 Aug 12, 2024	SELL	$314.68 - $395.94 $39,335 - $49,492	-125 Reduced 15.98%	657 $216,000
Q1 2024 May 15, 2024	SELL	$338.27 - $413.0 $10,486 - $12,803	-31 Reduced 3.81%	782 $309,000
Q4 2023 Feb 08, 2024	BUY	$318.29 - $392.21 $3,501 - $4,314	11 Added 1.37%	813 $286,000
Q3 2023 Nov 14, 2023	BUY	$354.9 - $412.41 $24,488 - $28,456	69 Added 9.41%	802 $300,000
Q2 2023 Aug 09, 2023	BUY	$334.63 - $382.47 $6,023 - $6,884	18 Added 2.52%	733 $280,000
Q1 2023 May 11, 2023	BUY	$232.5 - $346.47 $48,592 - $72,412	209 Added 41.3%	715 $247,000
Q4 2022 Feb 10, 2023	BUY	$209.34 - $261.61 $2,721 - $3,400	13 Added 2.64%	506 $119,000
Q3 2022 Nov 10, 2022	SELL	$246.08 - $343.65 $15,995 - $22,337	-65 Reduced 11.65%	493 $121,000
Q2 2022 Aug 09, 2022	BUY	$280.61 - $420.45 $23,851 - $35,738	85 Added 17.97%	558 $169,000
Q1 2022 May 06, 2022	BUY	$357.49 - $445.92 $15,372 - $19,174	43 Added 10.0%	473 $194,000
Q4 2021 Feb 01, 2022	BUY	$402.25 - $471.34 $24,135 - $28,280	60 Added 16.22%	430 $202,000
Q3 2021 Nov 12, 2021	BUY	$363.01 - $468.47 $5,808 - $7,495	16 Added 4.52%	370 $157,000
Q2 2021 Aug 09, 2021	BUY	$284.77 - $363.2 $4,556 - $5,811	16 Added 4.73%	354 $127,000
Q1 2021 May 12, 2021	BUY	$257.29 - $307.53 $24,442 - $29,215	95 Added 39.09%	338 $95,000
Q4 2020 Feb 16, 2021	SELL	$261.16 - $301.66 $9,662 - $11,161	-37 Reduced 13.21%	243 $69,000
Q3 2020 Nov 13, 2020	BUY	$224.99 - $288.02 $16,874 - $21,601	75 Added 36.59%	280 $77,000
Q2 2020 Aug 13, 2020	SELL	$149.8 - $227.17 $61,567 - $93,366	-411 Reduced 66.72%	205 $47,000
Q1 2020 May 15, 2020	BUY	$128.96 - $174.76 $8,124 - $11,009	63 Added 11.39%	616 $95,000
Q2 2019 Jul 24, 2019	BUY	$111.27 - $125.15 $26,148 - $29,410	235 Added 73.9%	553 $66,000
Q1 2019 Apr 29, 2019	BUY	$94.53 - $110.2 $20,323 - $23,693	215 Added 208.74%	318 $32,000
Q2 2018 Aug 09, 2018	BUY	$83.32 - $101.88 $83 - $101	1 Added 0.98%	103 $9,000
Q3 2017 Oct 13, 2017	BUY	$84.54 - $96.75 $2,198 - $2,515	26 Added 34.21%	102 $9,000
Q2 2017 Aug 15, 2017	BUY	N/A	76	76 $2,000

Others Institutions Holding WST

# of Institutions

804

Shares Held

64.2M

Call Options Held

282K

Put Options Held

161K

View Full List

About WEST PHARMACEUTICAL SERVICES INC

Ticker WST
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 74,033,000
Market Cap $25B
Description
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers sto...

More about WST

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Quadrant Capital Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quadrant Capital Group LLC with notifications on news.

Account

Quadrant Capital Group LLC West Pharmaceutical Services Inc Transaction History